Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiorenal interactions during treatment of decompensated heart failure: diuretics versus ultrafiltration (CRUF Trial)
2009-017589-22Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bumetanide in heart failure (HF) and heart failure with reduced ejection fraction (HFrEF) (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Evaluation of renal function determinants with ultrafiltration vs diuretics. Started Dec 2009; status: completed.
02
Drugs
bumetanide
03
Conditions
heart failure (HF)heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on 2009-017589-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017589-22.